Chief Investment Officer,  Human Healthcare Technology Specialist & Board Director 

Matt McNamara is passionate about commercialising promising human healthcare technologies.

His business acumen combined with a strong background in the life sciences sector makes him one of the industry’s most credible investment voices.

​Currently, Matt continues to invest in and commercialise great healthcare technologies through an exciting portfolio of executive/non-executive board and advisory roles. 

​Previously, Matt spent over 30 years in the healthcare and medical sciences sector, with more than 20 years as a venture capitalist. He spent fourteen years as CIO at BioScience Managers (4 funds. $200M FUM. >20% IRR), and was previously CEO of SciCapital pre-seed fund. Prior to that he served as SVP Business Development for eBioinformatics Inc.

 Early in his career, Matt spent over a decade in the Pharma industry working in sales and marketing with Merck & Co. and in general management at Johnson and Johnson Medical Pty Ltd. 

​Matt has a BSc (Hons) in Molecular Biology, an MBA, and is a GAICD.